evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract
6011,GENE_SUMMARY,,"ASXL2, a tumor suppressor and epigenetic regulator, is mutated in various cancers including acute myeloid leukemias.",,2017-10-23,,55252,ASXL2,"additional sex combs like 2, transcriptional regulator",False,ENST00000435504,NM_018263.4,ASXH2,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6012,GENE_BACKGROUND,,"ASXL2 is a member of the Polycomb group of proteins, and is a chromatin binder that is involved in transcription regulation. ASXL2 is a member of the ASXL gene family that includes ASXL1, ASXL2 and ASXL3, which all have a C-terminal plant homology domain (PHD domain) that is predicted to recognize histone H3 tails via methylated lysines (PMID: 23147254). ASXL2 shares several conserved domains with ASXL1, a protein that regulates gene expression by interaction with the chromatin Polycomb Repressive Complex 2 (PRC2), and mutations in these genes are mutually exclusive in acute myeloid leukemia (AML), suggesting they may have similar functions and may contribute to transformation in the same way (PMID: 23147254, 19270745, 12888926). ASXL2 interacts with the chromatin-modifying enzyme BAP1 (PMID: 22878500), has been found to regulate nuclear receptors such as the retinoic acid receptor, LXRα and PPARγ (PMID: 25065743, 24321552, 21047783) and was identified as a protein that regulates bone density such that deletion of ASXL2 leads to deficient osteoclast formation in mice (PMID:21490954, 26051940).",,2017-10-18,,55252,ASXL2,"additional sex combs like 2, transcriptional regulator",False,ENST00000435504,NM_018263.4,ASXH2,True,25065743,WTIP interacts with ASXL2 and blocks ASXL2-mediated activation of retinoic acid signaling.,Biochemical and biophysical research communications,2018-08-15T20:14:00,451,True,101-6,Khan FF et al,doi: 10.1016/j.bbrc.2014.07.080,,0001-08-15,,22878500,Loss of the tumor suppressor BAP1 causes myeloid transformation.,"Science (New York, N.Y.)",2018-09-21T20:12:00,337,6101,1541-6,Dey A et al,,,0001-09-21,,21490954,Mouse genome-wide association and systems genetics identify Asxl2 as a regulator of bone mineral density and osteoclastogenesis.,PLoS genetics,2018-04-01T20:11:00,7,4,e1002038,Farber CR et al,doi: 10.1371/journal.pgen.1002038,,0001-04-01,,19270745,"Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx.",PloS one,2009,4,3,e4750,Baskind HA et al,doi: 10.1371/journal.pone.0004750,,Baskind HA et al. PloS one. 2009;4(3)e4750.,,26051940,"ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis.",Cell reports,2018-06-16T20:15:00,11,10,1625-37,Izawa T et al,doi: 10.1016/j.celrep.2015.05.019,,0001-06-16,,21047783,Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma}.,The Journal of biological chemistry,2018-01-14T20:11:00,286,2,1354-63,Park UH et al,doi: 10.1074/jbc.M110.177816,,0001-01-14,,24321552,Reciprocal regulation of LXRα activity by ASXL1 and ASXL2 in lipogenesis.,Biochemical and biophysical research communications,2018-01-10T20:14:00,443,2,489-94,Park UH et al,doi: 10.1016/j.bbrc.2013.11.124,,0001-01-10,,12888926,Identification and characterization of ASXL2 gene in silico.,International journal of oncology,2018-09-01T20:03:00,23,3,845-50,Katoh M et al,,,0001-09-01,,23147254,"The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.",Leukemia,2018-01-01T20:13:00,27,True,2001-10-05,Abdel-Wahab O et al,doi: 10.1038/leu.2012.288,,0001-01-01,
